
This is a preliminary study in which both acute and chronic oral administration of zzso zzso zzso was examined in the zzso diabetic fatty zzso zzso an animal model that develops overt zzso in the presence of zzso followed by zzso zzso At zzso weeks of age, in the presence of zzso zzso and zzso an acute oral zzso dose response was conducted to determine zzso properties of zzso time of response and effect of zzso on plasma insulin zzso zzso of zzso greater than zzso zzso resulted in plasma zzso levels of less than 9 zzso The highest dose administered zzso zzso significantly reduced plasma insulin zzso zzso zzso zzso zzso zzso and plasma zzso zzso zzso zzso zzso zzso zzso zzso At 15 weeks of age, in the presence of zzso zzso and normal insulin levels, zzso was administered orally in the drinking water for a zzso period to determine the effect of treatment on zzso insulin and zzso zzso zzso treatment significantly reduced plasma zzso levels zzso zzso zzso zzso zzso zzso zzso and effectively preserved pancreatic zzso zzso These data suggest a role for zzso as a therapeutic agent in zzso diabetes zzso through improvement in zzso zzso and preservation of insulin zzso 

